ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Enveric Biosciences Inc

Enveric Biosciences Inc (ENVB)

0.76
-0.005
(-0.65%)
Closed June 09 4:00PM
0.7373
-0.0227
(-2.99%)
After Hours: 5:11PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.7373
Bid
0.7373
Ask
1.15
Volume
111,752
0.73 Day's Range 0.78
0.649 52 Week Range 4.60
Market Cap
Previous Close
0.765
Open
0.75
Last Trade Time
Financial Volume
$ 83,957
VWAP
0.751277
Average Volume (3m)
1,505,074
Shares Outstanding
2,321,315
Dividend Yield
-
PE Ratio
-0.10
Earnings Per Share (EPS)
-7.52
Revenue
-
Net Profit
-17.46M

About Enveric Biosciences Inc

Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline include... Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Enveric Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENVB. The last closing price for Enveric Biosciences was $0.77. Over the last year, Enveric Biosciences shares have traded in a share price range of $ 0.649 to $ 4.60.

Enveric Biosciences currently has 2,321,315 shares outstanding. The market capitalization of Enveric Biosciences is $1.76 million. Enveric Biosciences has a price to earnings ratio (PE ratio) of -0.10.

ENVB Latest News

Enveric Biosciences to Participate in BIO International Convention 2024

Enveric Biosciences (NASDAQ: ENVB) (ā€œEnvericā€ or the ā€œCompanyā€), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of...

Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results

Revealed seven classes of promising novel drug candidates discovered using Envericā€™s Psybraryā„¢ and PsyAIā„¢ drug discovery and artificial intelligence (AI) platforms Launched business development...

Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders

MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds Enveric Biosciences...

Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids

Biotechnology licensee expected to progress methods targeting breast and other cancers using cannabinoids in combination with chemotherapeutic drugs Enveric Biosciences, Inc (NASDAQ: ENVB), a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0127-1.693333333330.750.79790.73843430.77733391CS
4-0.1617-17.98665183540.8990.9450.72732454810.84591224CS
12-0.4027-35.32456140351.141.870.727315050741.10693273CS
26-0.7627-50.84666666671.52.920.64924240141.32875604CS
52-3.8027-83.75991189434.544.60.64912387641.36810436CS
156-1.6527-69.15062761512.3914.870.155116350031.9633572CS
260-5.0627-87.28793103455.814.870.155120275132.58309685CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CLEUChina Liberal Education Holdings Ltd
$ 3.1505
(55.97%)
18.32M
HUDAHudson Acquisition I Corporation
$ 16.6999
(52.51%)
636.05k
VEROVenus Concept Inc
$ 0.893101
(52.22%)
69.53M
HRYUHanryu Holdings Inc
$ 0.5047
(40.55%)
2.83M
HUDAUHudson Acquisition I Corporation
$ 15.77
(30.22%)
3.77k
DSYBig Tree Cloud Holdings Limited
 1.9091
(-74.67%)
359.21k
BMEABiomea Fusion Inc
$ 4.14
(-63.27%)
11.22M
NBSTWNewbury Street Acquisition Corporation
$ 0.0374
(-32.00%)
174.15k
DHACUDigital Health Acquisition Corporation
$ 15.90
(-30.20%)
2.1k
SCNIScinai Immunotherapeutics Ltd
$ 2.97
(-28.41%)
706.54k
FFIEFaraday Future Intelligent Electric Inc
$ 0.602
(10.66%)
419.77M
PRSTPresto Technologies Inc
$ 0.09
(18.58%)
325.8M
SQQQProShares UltraPro Short QQQ
$ 9.32
(0.32%)
120.35M
CRKNCrown Electrokinetics Corporation
$ 0.0902
(3.20%)
119.61M
GERNGeron Corp
$ 4.60
(18.25%)
98.94M

ENVB Discussion

View Posts
Monksdream Monksdream 1 month ago
Mighty fluffy press release
šŸ‘ļø0
Awl416 Awl416 1 month ago
Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids
šŸ‘ļø0
Awl416 Awl416 3 months ago
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
šŸ‘ļø0
Monksdream Monksdream 3 months ago
ENVB under $2
šŸ‘ļø0
glenn1919 glenn1919 3 months ago
ENVB.........................................https://stockcharts.com/h-sc/ui?s=ENVB&p=W&b=5&g=0&id=p86431144783
šŸ‘ļø0
Invest-in-America Invest-in-America 3 months ago
ENVB: The Pro's are now workin' on their THIRD-NICE-FLIP behind this (easy money) puppy today!!! (I.e., one 100%-profit flip in the Pre-M, & now TWO circa 25-to-30%-profit flips in the Open-M!!! Yet STUPID traders cry about "Wash Trades". L.M.M.F.A.O.!!!!!)
šŸ‘ļø0
Invest-in-America Invest-in-America 3 months ago
ENVB: Heck, "Wash-Trades" keep those PROFITS nice & CLEAN!!!!
šŸ‘ļø0
Monksdream Monksdream 3 months ago
Wash trade du jour
šŸ‘ļø0
Invest-in-America Invest-in-America 3 months ago
ENVB: I'm buyin' latte's for everyone later today, up on the MOON!!!
šŸ‘ļø0
Invest-in-America Invest-in-America 3 months ago
ENVB: 3-bagger from here, whether anybody likes it or not!! (Just the way it goes, these days!!)
šŸ‘ļø0
TimeFades TimeFades 3 months ago
Nasty trap
šŸ‘ļø0
TimeFades TimeFades 3 months ago
Short
šŸ‘ļø0
tw0122 tw0122 3 months ago
The term sheets further provide that, Enveric could be eligible to receive future development and sales milestone payments and execution fees for the three licenses, which in total could add up to $200 million, assuming certain conditions are met, including receiving approval for the investigational new drug (IND) applications and completing Phases I through III testing of the licensed products. Royalty rates on each of the three licenses could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria. The compound classes under the term sheets come from two of the seven portfolios of preclinical molecules that Enveric recently unveiled as available for out-licensing. Numerous molecules and classes remain available for additional out-licensing opportunities.

ā€œPatients living with serious mental health conditions have seen insufficient innovation for far too long, and we are excited for the opportunity to progress several of the novel compounds generated using our drug discovery engine,ā€ said Joseph Tucker, Ph.D., Director and CEO of Enveric. ā€œWe look forward to working with our partner, and we are confident in their leadership and capabilities to work on further developing these drug candidates to advance treatment options for patients. Ultimately, we believe the definitive licensing agreements, once negotiated and finalized, could represent an excellent potential source of revenue for Enveric, and could demonstrate the value creation from Envericā€™s discovery capabilities and proprietary PsyAI™ and Psybrary™ platforms, which have already generated an impressive library of compounds targeting a variety of CNS disorders.ā€
šŸ‘ļø0
glenn1919 glenn1919 3 months ago
ENVB.........................................https://stockcharts.com/h-sc/ui?s=ENVB&p=W&b=5&g=0&id=p86431144783
šŸ‘ļø0
Awl416 Awl416 4 months ago
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
šŸ‘ļø0
I-Glow I-Glow 9 months ago
What's the patent application number?

IG
šŸ‘ļø0
Awl416 Awl416 10 months ago
4.96 to 3 blink of any eye
šŸ‘ļø0
Triple nickle Triple nickle 1 year ago
7.52 easy
šŸ‘ļø0
Jess070283 Jess070283 1 year ago
$4-$5.75. Done for the day. Wooo
šŸ‘ļø0
Awl416 Awl416 1 year ago
Enveric Biosciences Receives Notice of Allowance From USPTO for C4-Carboxylic Acid-Substituted Tryptamine Derivatives for Next Generation Psilocin Prodrug
šŸ‘ļø0
PennyPusher786 PennyPusher786 1 year ago
Nice flipper
šŸ‘ļø0
Triple nickle Triple nickle 1 year ago
Ok it cooled off
Five dollar run
šŸ‘ļø0
PennyPusher786 PennyPusher786 1 year ago
Now a Rug Pooool candidate lol... Now it's too dangerous... It can run 4+ but it can dump too as seen from 4.20s to 3.20s in all of 15 seconds
šŸ‘ļø0
PennyPusher786 PennyPusher786 1 year ago
Another rip or another dump, only the devil knows
šŸ‘ļø0
PennyPusher786 PennyPusher786 1 year ago
Good call. Ran to 4.20s and dumped to 3.20s
šŸ‘ļø0
Triple nickle Triple nickle 1 year ago
Iā€™m out
šŸ‘ļø0
surf1944 surf1944 1 year ago
https://stockcharts.com/h-sc/ui?s=envb&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/envb/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/envb/opinion

Open gap at $1.52
šŸ‘ļø0
PennyPusher786 PennyPusher786 1 year ago
There's another pullback
šŸ‘ļø0
Invest-in-America Invest-in-America 1 year ago
Ooooooops!! (iHub posting error, glitch, etc.).
šŸ‘ļø0
Invest-in-America Invest-in-America 1 year ago
ENVB: I'm workin' on an ANSWER to your question right now, Sir. (See my 'Chart' on this, below.)

šŸ‘ļø0
TheFinalCD TheFinalCD 1 year ago
WALL @ 3.50 JUST TAKEN OUT
šŸ‘ļø0
PennyPusher786 PennyPusher786 1 year ago
Anyone smell a bait and pull? Lol or do we forsee $5- 6
šŸ‘ļø0
Invest-in-America Invest-in-America 1 year ago
ENVB: See ya-all up on the MOON later, Folks!!
šŸ‘ļø0
PennyPusher786 PennyPusher786 1 year ago
Same. I expect pullbacks and runs if the volume stays consistent.. which means mass flipping
šŸ‘ļø0
Triple nickle Triple nickle 1 year ago
Watching
šŸ‘ļø0
PennyPusher786 PennyPusher786 1 year ago
This could run 5 - 6 today.
šŸ‘ļø0
Triple nickle Triple nickle 1 year ago
Sell down now
šŸ‘ļø0
Awl416 Awl416 1 year ago
Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
šŸ‘ļø0
DDA DDA 2 years ago
The RS already took place. Don't understand why my post would need to ve deleted
šŸ‘ļø0
Klinsmann Klinsmann 2 years ago
But gonna be a nice entry soon imo
šŸ‘ļø0
Roadtojourney Roadtojourney 2 years ago
Rs and dilution followed right after wow??
šŸ‘ļø0
DDA DDA 2 years ago
Reverse split just anounced
šŸ‘ļø0
BoilerRoom BoilerRoom 2 years ago
What are other biotech stocks Iā€™m not familiar with this sector. Appreciate your feedback MASTERULTRA you seem to know about these.
šŸ‘ļø0
MASTERULTRA MASTERULTRA 2 years ago
Seriously, WTF!!! this company should be trending higher due to 04/20...

I fucking hope the people who short this or manipulate this gets Karma.
šŸ‘ļø0
DallasInvest DallasInvest 2 years ago
The douche canoe Dj front load of the day lol
šŸ‘ļø0
TommyBoyTrader9460 TommyBoyTrader9460 2 years ago
$ENVB Added..looks like interest building here..
šŸ‘ļø0
kzivann kzivann 2 years ago
Back on watch .. Bottom or how much lower?

ENVB
šŸ‘ļø0
The ELTP King The ELTP King 2 years ago
Agreed.

This company is a total loser with zero revenue.

Absolute embarrassment.

New CFO Carter Ward ran this company into the ground in just 9 months.

Delist imminent or reverse split.





šŸ‘ļø0
NASDAQ2020 NASDAQ2020 2 years ago
Delist imminent or reverse split.
šŸ‘ļø0
Jake L Jake L 3 years ago
ENVB - Thursday Rundown, Friday Expectations

šŸ‘ļø0